DexCom, Inc. (DXCM)
67.42
+0.56
(+0.84%)
USD |
NASDAQ |
Dec 24, 16:00
DexCom Market Cap: 26.29B for Dec. 24, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 217.03B |
| BioLife Solutions, Inc. | 1.223B |
| Boston Scientific Corp. | 142.51B |
| Tandem Diabetes Care, Inc. | 1.524B |
| Sotera Health Co. | 5.028B |
Market Cap Related Metrics
| PE Ratio | 37.52 |
| PS Ratio | 6.083 |
| PEG Ratio | 4.867 |
| Price to Book Value | 9.646 |
| Price to Free Cash Flow | 25.87 |
| Price | 67.42 |
| Earnings Yield | 2.67% |
| PEGY Ratio | 4.867 |
| Operating PE Ratio | 35.32 |
| Normalized PE Ratio | 37.52 |